Legal protection of the rights of clinical trial subjects in China

Yuanpeng Ren, Xinrui Jin, Shan Jiang, Baisheng Jiang

PDF(89 KB)
PDF(89 KB)
Journal of Biomedical Research ›› 2018, Vol. 32 ›› Issue (2) : 77-80. DOI: 10.7555/JBR.32.20170073
Perspective

Legal protection of the rights of clinical trial subjects in China

Author information +
History +

Cite this article

Download citation ▾
Yuanpeng Ren, Xinrui Jin, Shan Jiang, Baisheng Jiang. Legal protection of the rights of clinical trial subjects in China. Journal of Biomedical Research, 2018, 32(2): 77‒80 https://doi.org/10.7555/JBR.32.20170073

References

[1]
World Medical Association. WMA declaration of Helsinki – ethical principles for medical research involving human subjects[C/OL]. The 18th WMA General Assembly, Helsinki, Finland, June 1964[2017-03-29]. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
[2]
Man HJ. Law study on human trials[D]. Shanghai: Fudan University, 2009.
[3]
Wei S, Cong HQ. Protection of human rights in clinical trials[J]. Med and Philos, 2011, 01: 17–19.
[4]
Shao R, Zhang Y, Wang ZM, Comparison on clinical drug research subjects between China and England from the perspective of ethics committee[J]. Chinese Pharmaceut Affairs, 2012, 09: 931–935.
[5]
Li JM. Discussion on standard management in institutional review board for clinical trials in China[J]. Zhongguo Lin Chuang Yao Li Xue Za Zhi, 2009, 25(2): 169–171.
[6]
Qiu R, Zhai XM. The construction of ethics review capacity in China under the current international conditions: Conception and Practice, Chinese[J]. Med Ethics (Burlingt, Mass), 2008, 21(2): 3–5.
[7]
Du WL. Wu D. Current situation and suggestion on drug clinical trials examined by ethics committee[J]. Chinese J Clin Ration Drug Use, 2014, 02: 159–160.
[8]
Zhang W. System establishment of subjects’ rights and interest protection in human trials[J]. Econom Res Guide, 2015, (3): 324–326.
[9]
Wu J, Tang Q. Legal issues on civil damage compensation lawsuit in new drug human trials[J]. The People’s Judicature (in Chinese), 2010, 07: 96–99.
[10]
Zheng S. Human trials under the perspective of civil litigation—in the perspective of subjects’ right to be informed[J]. Law Sci Magazine, 2012, 33(4): 180–185.
[11]
Xin L. A study of the legal issue about the drug clinical trial involved minor subjects[J]. Med and Philos, 2009, 02: 48–50.

Acknowledgments

This article was funded by the National Social Science Foundation of China (Grant No.14BFX161).

RIGHTS & PERMISSIONS

2018 2018 by the Journal of Biomedical Research.
PDF(89 KB)

Accesses

Citations

Detail

Sections
Recommended

/